A0A0S2Z448 (A0A0S2Z448_HUMAN) Homo sapiens (Human)
Myeloid/lymphoid or mixed-lineage leukemia translocated to 3 isoform 1 UniProtKBInterProInteractive Modelling
568 aa; Sequence (Fasta) ;
5 identical sequences: Homo sapiens: P42568; Pongo abelii: A0A2J8XIC3; Cercocebus atys: A0A2K5KJE5; Nomascus leucogenys: A0A2I3HQI2; Piliocolobus tephrosceles: A0A8C9H0V6
It is possible new templates exist for this target since these models were created.
Available Structures
19 Experimental Structures
| Description | PDB ID | Oligo-state | Range | Ligands | ||
|---|---|---|---|---|---|---|
| Crystal structure of AF9 YEATS domain in complex with histone H3K9bu |
Heteromer P42568; P68431; | 1×PEG; | ||||
| Assess | ||||||
| Crystal structure of AF9 YEATS domain in complex with H4K5acK8ac peptide |
Heteromer P42568; P62805; | 2×GOL; 1×PEG; | ||||
| Assess | ||||||
| Crystal structure of AF9 YEATS domain in complex with H4K8acK12ac peptide |
Heteromer P42568; P62805; | 1×GOL; | ||||
| Assess | ||||||
| Crystal Structure of YEATS domain of AF9 in complex with H3K9bz peptide |
Heteromer P42568; P68431; | |||||
| Assess | ||||||
| Crystal structure of AF9 YEATS bound to H3K9ac peptide |
Heteromer P42568; P84243; | 1×EDO; | ||||
| Assess | ||||||
| AF9 YEATS in complex with histone H3 Crotonylation at K9 |
Heteromer P42568; P68431; | |||||
| Assess | ||||||
| AF9 YEATS in complex with histone H3 Crotonylation at K18 |
Heteromer P42568; P68431; | 3×CU; 8×SO4; | ||||
| Assess | ||||||
| Solution NMR structures of AF9 yeats domain in complex with histone H3 crotonylation at K18 |
Heteromer P42568; P68431; | |||||
| Assess | ||||||
| Solution NMR structures of AF9 yeats domain in complex with histon H3 acetylation at K18 |
Heteromer P42568; P68431; | |||||
| Assess | ||||||
| Crystal structure of AF9 YEATS domain Y78W mutant in complex with histone H3K9cr |
Heteromer P42568; P68431; | |||||
| Assess | ||||||
| Solution NMR structure of BCoR in complex with AF9 (BCoR-AF9) |
Heteromer P42568; Q6W2J9; | |||||
| Assess | ||||||
| Solution NMR structure of CBX8 in complex with AF9 (CBX8-AF9) |
Heteromer P42568; Q9HC52; | |||||
| Assess | ||||||
| Solution NMR structure of DOT1L in complex with AF9 (DOT1L-AF9) |
Heteromer P42568; Q8TEK3; | |||||
| Assess | ||||||
| MLLT3 in complex with compound PFI-6 | monomer | 1×ZJ9; 6×EDO; 1×DMS; 1×PO4; | ||||
| Assess | ||||||
| Crystal structure of AF9 YEATS domain in complex with a peptide inhibitor "PHQ-H3(Q5-K9)" modified … | monomer | 2×SO4; 1×FOA; | ||||
| Assess | ||||||
| Crystal strucutre of AF9 YEATS domain in complex with a cyclopeptide inhibitor | monomer | |||||
| Assess | ||||||
| Crystal structure of AF9 YEATS domain in complex with Compound 10 | monomer | 1×7IV; 1×CL; 4×EDO; | ||||
| Assess | ||||||
| Crystal structure of AF9 YEATS domain in complex with hit 2 | monomer | 1×7IY; 1×GOL; | ||||
| Assess | ||||||
| Solution structure of the AF4-AF9 complex | monomer | |||||
| Assess | ||||||
2 SWISS-MODEL models
| Template | Oligo-state | QMEANDisCo | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|
| 7x8g.1.A | monomer | 0.79 | 77.55 | |||
| Assess | ||||||
| 2lm0.1.A | monomer | 0.61 | 87.23 | |||
| Assess | ||||||